Hillevax

Acquired

XOMA Royalty – A biotech royalty aggregator

Hillevax was founded in 2021, is headquartered in Boston, United States, lists 11–50 employees, and has $136.3M in recorded funding across 2 rounds.

Employees
11–50
Founded
2021
Business Model
B2B
Total Funding
$136.3M
Last Round
$135.0M Series DSep 2021
Rounds
2
Type
Public
Acquired by
XOMA

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 4 investors for this company. The full record is or through the API.

About

HilleVax is a clinical-stage biopharmaceutical company focused on developing vaccines. Lead program HIL-214 is a bivalent VLP vaccine candidate for moderate-to-severe acute gastroenteritis from norovirus in infants. Founded 2021, HQ Boston. Raised $136M. Phase 2b trial showed limited efficacy 2024. Website now redirects to XOMA Royalty.

Summary

Hillevax is a Biotech company based in Boston, United States, founded in 2021. It lists 11–50 employees. It has raised $136.3M in total across 2 rounds, most recently a $135.0M Series D round in Sep 2021. Investors include Frazier Healthcare, Takeda (JP) and Lightspeed Venture Partners.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

IPOMay 2022
$230.0M

Sign up to see all 4 events

Funding: Convertible Note through Series D. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Hillevax on Indexed.vc
<a href="https://indexed.vc/companies/hillevax"><img src="https://indexed.vc/api/badge/company/hillevax" alt="Hillevax on Indexed.vc" width="260" height="76" /></a>